The purpose of the present study was to determine whether breast tumours developed by ATM variant carriers show distinctive histopathological and genomic features as compared with ‘sporadic’ tumours, and also whether they resemble the breast tumours described in carriers of a deleterious variant of other known BC susceptibility genes, in particular the BRCA1-associated phenotype [18]. The gene discussed is ATM; the disease is breast neoplasm.